Literature DB >> 938128

Pulmonary aspergillosis: an analysis of 41 patients.

A Karas, J R Hankins, S Attar, J E Miller, J S McLaughlin.   

Abstract

During the period 1969 to 1974, 41 patients having cultures positive for aspergillus were seen on the thoracic surgical services of the University of Maryland and Mt. Wilson State Hospitals. Intracavitary mycetoma was present in 36 patients. In 32 the underlying disease was chronic cavitary tuberculosis, 5 had decreased immunity due to other diseases, and in 3 no underlying disease was noted. One final patient developed a mycetoma following repair of tetralogy of Fallot. Hemoptysis, the predominant symptom, occurred in 23 patients, all of whom were from the group with intracavitary mycetoma. Hemoptysis was life-threatening in 8 patients, severe but not life-threatening in 12, and minimal in 3. Fifteen patients underwent pulmonary resection with 2 deaths. Both patients who died had undergone emergency resection for life-threatening hemoptysis; the fungus ball had developed following a previous resection for tuberculosis, and both had poor pulmonary reserve. Of 10 patients with hemoptysis who were not treated surgically, chiefly because they were poor operative risks, 4 died. This study suggests that pulmonary aspergillosis, particularly of the intracavitary type, is a potentially life-threatening disease. Because of the suddenness with which massive hemoptysis may occur, pulmonary resection is recommended for all patients with intracavitary mycetoma who do not constitute prohibitive operative risks.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938128     DOI: 10.1016/s0003-4975(10)63943-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

Authors:  L B Palmer; H E Greenberg; M J Schiff
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

2.  The air crescent sign: causes and characteristics.

Authors:  Herbert L Fred; Carolyn L Gardiner
Journal:  Tex Heart Inst J       Date:  2009

Review 3.  Aspergilloma and the surgeon.

Authors:  Loven Moodley; Jehron Pillay; Keertan Dheda
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

4.  Recent experience of the treatment of aspergilloma with a surgical stapling device.

Authors:  A Allan; B Sethia; M A Turner
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

5.  Indications and outcome of surgery for pulmonary aspergilloma.

Authors:  R el Oakley; M Petrou; P Goldstraw
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

6.  What happens to patients with pulmonary aspergilloma? Analysis of 23 cases.

Authors:  P Rafferty; B A Biggs; G K Crompton; I W Grant
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

7.  Limited thoracoplasty in the management of complicated pulmonary aspergillomas.

Authors:  M al-Zeerah; K Jeyasingham
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

8.  Management of post-tuberculous complex aspergilloma of the lung: role of surgical resection.

Authors:  S A al-Majed; M Ashour; F A el-Kassimi; I Joharjy; A al-Wazzan; M S al-Hajjaj; R Vijay
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

9.  Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment.

Authors:  J Jewkes; P H Kay; M Paneth; K M Citron
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

10.  Air-borne fungi in the air of Barcelona (Spain). II. The genus alternaria.

Authors:  M A Calvo; J Guarro; G Suarez; C Ramírez
Journal:  Mycopathologia       Date:  1979-12-28       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.